Efficacy and safety of glycopyrrolate/eFlow® CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials
Autor: | Kerwin, Edward, Donohue, James F., Goodin, Thomas, Tosiello, Robert, Wheeler, Alistair, Ferguson, Gary T. |
---|---|
Zdroj: | In Respiratory Medicine November 2017 132:238-250 |
Databáze: | ScienceDirect |
Externí odkaz: |